These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 21955369)

  • 1. Molecular pharmacological profile of a novel thiazolinone-based direct and selective 5-lipoxygenase inhibitor.
    Hofmann B; Rödl CB; Kahnt AS; Maier TJ; Michel AA; Hoffmann M; Rau O; Awwad K; Pellowska M; Wurglics M; Wacker M; Zivković A; Fleming I; Schubert-Zsilavecz M; Stark H; Schneider G; Steinhilber D
    Br J Pharmacol; 2012 Apr; 165(7):2304-13. PubMed ID: 21955369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A class of 5-benzylidene-2-phenylthiazolinones with high potency as direct 5-lipoxygenase inhibitors.
    Hofmann B; Barzen S; Rödl CB; Kiehl A; Borig J; Zivković A; Stark H; Schneider G; Steinhilber D
    J Med Chem; 2011 Mar; 54(6):1943-7. PubMed ID: 21341744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological evaluation of a class of 5-benzylidene-2-phenyl-thiazolinones as potent 5-lipoxygenase inhibitors.
    Barzen S; Rödl CB; Lill A; Steinhilber D; Stark H; Hofmann B
    Bioorg Med Chem; 2012 Jun; 20(11):3575-83. PubMed ID: 22551629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conjugation of 4-aminosalicylate with thiazolinones afforded non-cytotoxic potent in vitro and in vivo anti-inflammatory hybrids.
    Abdu-Allah HHM; Abdelmoez AAB; Tarazi H; El-Shorbagi AA; El-Awady R
    Bioorg Chem; 2020 Jan; 94():103378. PubMed ID: 31677858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A rat air pouch model for evaluating the efficacy and selectivity of 5-lipoxygenase inhibitors.
    Zweifel BS; Hardy MM; Anderson GD; Dufield DR; Pufahl RA; Masferrer JL
    Eur J Pharmacol; 2008 Apr; 584(1):166-74. PubMed ID: 18295198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular pharmacological profile of the nonredox-type 5-lipoxygenase inhibitor CJ-13,610.
    Fischer L; Steinhilber D; Werz O
    Br J Pharmacol; 2004 Jul; 142(5):861-8. PubMed ID: 15197110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inversely-correlated inhibition of human 5-lipoxygenase activity by BAY X1005 and other quinoline derivatives in intact cells and a cell-free system--implications for the function of 5-lipoxygenase activating protein.
    Hatzelmann A; Goossens J; Fruchtmann R; Mohrs KH; Raddatz S; Müller-Peddinghaus R
    Biochem Pharmacol; 1994 Jun; 47(12):2259-68. PubMed ID: 8031320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The molecular mechanism of the inhibition by licofelone of the biosynthesis of 5-lipoxygenase products.
    Fischer L; Hornig M; Pergola C; Meindl N; Franke L; Tanrikulu Y; Dodt G; Schneider G; Steinhilber D; Werz O
    Br J Pharmacol; 2007 Oct; 152(4):471-80. PubMed ID: 17704828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mode of action of the new selective leukotriene synthesis inhibitor BAY X 1005 ((R)-2-[4-(quinolin-2-yl-methoxy)phenyl]-2-cyclopentyl acetic acid) and structurally related compounds.
    Hatzelmann A; Fruchtmann R; Mohrs KH; Raddatz S; Müller-Peddinghaus R
    Biochem Pharmacol; 1993 Jan; 45(1):101-11. PubMed ID: 8381000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel class of benzimidazole-thiazole hybrids: The privileged scaffolds of potent anti-inflammatory activity with dual inhibition of cyclooxygenase and 15-lipoxygenase enzymes.
    Maghraby MT; Abou-Ghadir OMF; Abdel-Moty SG; Ali AY; Salem OIA
    Bioorg Med Chem; 2020 Apr; 28(7):115403. PubMed ID: 32127262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of spirostanol glycosides and furostanol glycosides from anemarrhenae rhizoma as dual targeted inhibitors of 5-lipoxygenase and Cyclooxygenase-2 by employing a combination of affinity ultrafiltration and HPLC/MS.
    Xie L; Lee DY; Shang Y; Cao X; Wang S; Liao J; Zhang T; Dai R
    Phytomedicine; 2020 Oct; 77():153284. PubMed ID: 32707371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclooxygenase (COX) and 5-lipoxygenase (5-LOX) selectivity of COX inhibitors.
    Sud'ina GF; Pushkareva MA; Shephard P; Klein T
    Prostaglandins Leukot Essent Fatty Acids; 2008 Feb; 78(2):99-108. PubMed ID: 18280718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and development of thiazole leads as COX-2/5-LOX inhibitors through in-vitro and in-vivo biological evaluation for anti-inflammatory activity.
    Jacob P J; Manju SL
    Bioorg Chem; 2020 Jul; 100():103882. PubMed ID: 32361295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and biological evaluation of isoxazolo[4,5-d]pyridazin-4-(5H)-one analogues as potent anti-inflammatory agents.
    Özadalı K; Özkanlı F; Jain S; Rao PP; Velázquez-Martínez CA
    Bioorg Med Chem; 2012 May; 20(9):2912-22. PubMed ID: 22475926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acetyl-11-keto-beta-boswellic acid (AKBA): structure requirements for binding and 5-lipoxygenase inhibitory activity.
    Sailer ER; Subramanian LR; Rall B; Hoernlein RF; Ammon HP; Safayhi H
    Br J Pharmacol; 1996 Feb; 117(4):615-8. PubMed ID: 8646405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis and biological evaluation of benzo[1.3.2]dithiazolium ylide 1,1-dioxide derivatives as potential dual cyclooxygenase-2/5-lipoxygenase inhibitors.
    Tan CM; Chen GS; Chen CS; Chang PT; Chern JW
    Bioorg Med Chem; 2011 Nov; 19(21):6316-28. PubMed ID: 21958737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis and identification of novel substituted 2-amino thiazole analogues as potential anti-inflammatory agents targeting 5-lipoxygenase.
    Sinha S; Doble M; Manju SL
    Eur J Med Chem; 2018 Oct; 158():34-50. PubMed ID: 30199704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potent inhibition of human 5-lipoxygenase and microsomal prostaglandin E₂ synthase-1 by the anti-carcinogenic and anti-inflammatory agent embelin.
    Schaible AM; Traber H; Temml V; Noha SM; Filosa R; Peduto A; Weinigel C; Barz D; Schuster D; Werz O
    Biochem Pharmacol; 2013 Aug; 86(4):476-86. PubMed ID: 23623753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacology of PF-4191834, a novel, selective non-redox 5-lipoxygenase inhibitor effective in inflammation and pain.
    Masferrer JL; Zweifel BS; Hardy M; Anderson GD; Dufield D; Cortes-Burgos L; Pufahl RA; Graneto M
    J Pharmacol Exp Ther; 2010 Jul; 334(1):294-301. PubMed ID: 20378715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and evaluation of ST-1829 based on 5-benzylidene-2-phenylthiazolones as promising agent for anti-leukotriene therapy.
    Lill AP; Rödl CB; Steinhilber D; Stark H; Hofmann B
    Eur J Med Chem; 2015 Jan; 89():503-23. PubMed ID: 25462262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.